Graham Watson

CardioPrecision Ltd. develops medical devices designed for minimally invasive cardiovascular surgery. The company is headquartered in Glasgow, the United Kingdom.

Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom.

Part of Galliford Try Holdings Plc, Scottish Futures Trust Investments Ltd. is a British company that provides venture and development capital services. The company is based in Edinburgh, UK and was founded in 2010.

Part of Galliford Try Holdings Plc, Scottish Futures Trust Investments Ltd. is a British company that provides venture and development capital services. The company is based in Edinburgh, UK and was founded in 2010.

Part of Galliford Try Holdings Plc, Scottish Futures Trust Investments Ltd. is a British company that provides venture and development capital services. The company is based in Edinburgh, UK and was founded in 2010.

CardioPrecision Ltd. develops medical devices designed for minimally invasive cardiovascular surgery. The company is headquartered in Glasgow, the United Kingdom.

Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom.

CardioPrecision Ltd. develops medical devices designed for minimally invasive cardiovascular surgery. The company is headquartered in Glasgow, the United Kingdom.

CardioPrecision Ltd. develops medical devices designed for minimally invasive cardiovascular surgery. The company is headquartered in Glasgow, the United Kingdom.

Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom.

Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom.

Part of Galliford Try Holdings Plc, Scottish Futures Trust Investments Ltd. is a British company that provides venture and development capital services. The company is based in Edinburgh, UK and was founded in 2010.

Scottish Futures Trust Ltd. operates as a trust. The non-profit company is based in Edinburgh, UK. The British company was founded in 2008. Peter Charles Maxwell Reekie has been the CEO of the company since 2017.

Scottish Futures Trust Ltd. operates as a trust. The non-profit company is based in Edinburgh, UK. The British company was founded in 2008. Peter Charles Maxwell Reekie has been the CEO of the company since 2017.

Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom.

Scottish Futures Trust Ltd. operates as a trust. The non-profit company is based in Edinburgh, UK. The British company was founded in 2008. Peter Charles Maxwell Reekie has been the CEO of the company since 2017.